Phosphoglycerol Transferase I (mdoB) catalyzes the transfer of phosphoglycerol residues from phosphatidylglycerol to membrane-derived oligosaccharides (MDOs) or model substrates like arbutin . In Salmonella agona, this enzyme is implicated in cell envelope biogenesis, influencing biofilm formation and stress adaptation, though direct linkages to virulence remain under investigation . Recombinant versions enable biochemical and structural studies without requiring native pathogen handling.
Vaccine Development: Recombinant mdoB is used to study antigenic properties in Salmonella vaccines, leveraging its surface-exposed epitopes .
Antimicrobial Resistance (AMR) Studies: While not directly linked to AMR in S. agona, mdoB’s role in membrane integrity may indirectly affect bacterial survival under stress .
Biofilm Studies: Reduced biofilm formation in S. agona carriage isolates suggests regulatory or structural dependencies on MDOs, though genetic evidence remains inconclusive .
KEGG: sea:SeAg_B4862
Phosphoglycerol transferase I (mdoB) is a membrane-bound enzyme that catalyzes the transfer of phosphoglycerol residues from phosphatidylglycerol to membrane-derived oligosaccharides (MDOs). In Salmonella agona, as in other gram-negative bacteria, this enzyme plays a critical role in membrane biogenesis and periplasmic osmoregulation. The enzyme is characterized as an integral membrane protein with its active site facing the periplasmic space, allowing it to modify surface oligosaccharides with phosphoglycerol residues .
The reaction catalyzed by mdoB can be represented as:
Phosphatidylglycerol + Membrane-derived oligosaccharide → Phosphoglycerol-substituted MDO + sn-1,2-diglyceride
This transfer reaction is significant for bacterial envelope integrity and has been implicated in adaptation to environmental osmotic changes. The genetic locus for mdoB maps near minute 99 on the bacterial chromosome, and mutations in this gene result in the production of MDOs lacking phosphoglycerol residues .
Recombinant Salmonella agona Phosphoglycerol transferase I is a full-length transmembrane protein consisting of 763 amino acids. The protein sequence begins with "MSELLSVALFLASVLIYAWKAGRNTWWFAATLTVLGLFVILNITLYASDYFTGDGINDAV..." and contains multiple transmembrane domains that anchor it within the cytoplasmic membrane . The protein has several functional domains including:
N-terminal transmembrane region
Catalytic domain that facilitates phosphoglycerol transfer
Substrate binding sites for both phosphatidylglycerol and membrane oligosaccharides
C-terminal region involved in proper folding and stability
When expressed recombinantly, the protein is typically produced with an N-terminal 10xHis-tag to facilitate purification while maintaining enzymatic function . The molecular structure reveals several conserved regions that are critical for its phosphotransferase activity.
For optimal stability and activity retention of recombinant Salmonella agona Phosphoglycerol transferase I, researchers should follow these evidence-based storage protocols:
| Storage Condition | Recommended Duration | Activity Retention |
|---|---|---|
| -20°C (standard) | Up to 6 months | ~85-90% |
| -80°C (extended) | 12+ months | >95% |
| 4°C (working aliquots) | Up to 1 week | ~75-80% |
Researchers should note several critical handling considerations:
Avoid repeated freeze-thaw cycles as these significantly diminish enzyme activity
Prepare working aliquots upon initial thawing to minimize protein degradation
Store in buffer systems containing stabilizing agents (glycerol, reducing agents)
Maintain sterile conditions during handling to prevent microbial contamination
For experiments requiring extended storage periods, lyophilization is recommended, extending shelf life to approximately 12 months when stored at -20°C or -80°C . Always validate enzyme activity after prolonged storage before conducting critical experiments.
The most effective expression system for producing functional recombinant Salmonella agona Phosphoglycerol transferase I is E. coli-based in vitro expression. This approach offers several advantages when optimized with the following parameters:
Expression vector selection: Vectors containing strong inducible promoters (T7, tac) with appropriate fusion tags (particularly N-terminal His-tags) yield highest recovery of functional protein
Host strain optimization: E. coli strains engineered for membrane protein expression (such as C41(DE3) or C43(DE3)) significantly improve yield of correctly folded mdoB
Induction conditions: Low-temperature induction (16-18°C) with reduced inducer concentration extends expression time and improves proper protein folding
Membrane fraction recovery: Careful isolation of membrane fractions using optimized lysis and centrifugation protocols is essential for preserving native conformation
The recombinant protein produced through these systems should be verified for proper folding and function through activity assays measuring phosphoglycerol transfer to appropriate substrates such as arbutin, which serves as a model substrate for activity verification .
Designing experiments to investigate substrate specificity of Phosphoglycerol transferase I requires a systematic approach using both natural and synthetic substrates. The following experimental framework addresses this complex question:
Construct a diverse substrate panel including:
Natural phosphatidylglycerol variants with different fatty acid compositions
Synthetic membrane-derived oligosaccharide analogues
Model substrates like arbutin (p-hydroxyphenyl-β-D-glucoside), which has been validated as an effective model substrate
Implement a Design of Experiments (DoE) approach to efficiently investigate multiple parameters simultaneously:
Vary substrate concentrations systematically across a physiologically relevant range
Test various reaction conditions (pH, temperature, ionic strength)
Direct measurement of phosphoglycerol transfer using radiolabeled substrates
Quantification of reaction products (particularly sn-1,2-diglyceride formation)
Monitoring substrate depletion rates using chromatographic methods
Apply statistical models to:
Generate Michaelis-Menten parameters for different substrates
Calculate relative specificity constants (kcat/KM)
This comprehensive experimental design enables researchers to elucidate substrate preferences and biochemical constraints of mdoB enzyme activity while minimizing experimental variability through systematic testing approaches.
To study mdoB function in vivo, researchers can employ several genetic approaches that provide comprehensive insights into the physiological roles of Phosphoglycerol transferase I:
The most definitive approach leverages the arbutin resistance phenotype as demonstrated in previous studies. When strains bearing the dgk mutation (defective in diglyceride kinase) are grown in media containing arbutin, they accumulate sn-1,2-diglyceride due to phosphoglycerol transferase I activity, resulting in growth inhibition. A secondary mutation in mdoB confers arbutin resistance by preventing this accumulation .
Experimental protocol:
Create dgk mutant strains using site-directed mutagenesis or transposon insertion
Culture cells on arbutin-containing media to select for spontaneous mdoB mutants
Confirm genotype through PCR and sequencing of the mdoB locus
Validate phenotype by assessing membrane-derived oligosaccharide composition
For confirming gene function and structure-function relationships:
Construct expression vectors containing wild-type or mutated mdoB genes
Transform these constructs into mdoB-deficient strains
Assess restoration of phosphoglycerol transfer activity and related phenotypes
Analyze membrane-derived oligosaccharides for phosphoglycerol content
This genetic approach has provided strong evidence for the in vivo function of phosphoglycerol transferase I in membrane-derived oligosaccharide biosynthesis and offers a platform for further investigation of protein domains and catalytic mechanisms .
Metabolic atom mapping provides powerful insights into the mechanistic details of mdoB-catalyzed phosphoglycerol transfer reactions by tracing the movement of individual atoms from substrates to products. This advanced approach reveals reaction mechanisms at atomic resolution:
Database Integration and Model Construction:
Incorporate mdoB reactions into metabolic atom mapping databases like MetAMDB
Ensure proper metabolite structure representation through MOL files with standardized atom numbering according to InChI conventions
Validate carbon balance (substrate carbon atoms must equal product carbon atoms) to ensure reaction completeness
Reaction Mechanism Analysis:
Track specific phosphoglycerol atoms from phosphatidylglycerol to membrane-derived oligosaccharides
Map the formation of sn-1,2-diglyceride byproducts to understand bond cleavage patterns
Identify potential reaction intermediates through transition state modeling
Isotopic Labeling Experimental Design:
Integration with Flux Analysis:
This comprehensive approach bridges computational and experimental methodologies, providing researchers with mechanistic understanding of phosphoglycerol transfer at atomic resolution while revealing the broader metabolic context of mdoB function.
Accurate quantification of Phosphoglycerol transferase I activity requires carefully selected analytical methods tailored to the unique characteristics of this membrane-associated enzyme. The following methodological approaches provide complementary data for comprehensive activity assessment:
Radiometric Assay
Substrate: [14C]-labeled phosphatidylglycerol
Detection: Quantification of radiolabeled phosphoglycerol transfer to acceptor molecules
Sensitivity: Capable of detecting femtomole-level activity
Advantages: High specificity and excellent signal-to-noise ratio
Arbutin-Based Spectrophotometric Assay
HPLC-Mass Spectrometry
Approach: Direct quantification of reaction products
Markers: Detection of sn-1,2-diglyceride formation and phosphoglycerol-MDO conjugates
Advantage: Provides structural confirmation of products alongside quantitative data
The table below outlines critical quality control parameters for mdoB activity assays:
| Parameter | Acceptable Range | Method of Verification |
|---|---|---|
| Specific Activity | >0.5 μmol/min/mg | Enzyme concentration titration |
| Linearity | R² >0.98 | Time-course experiments |
| Reproducibility | CV <10% | Replicate analysis |
| Background | <5% of signal | No-enzyme controls |
When analyzing complex biological samples, researchers should implement appropriate controls to account for potential interfering activities and ensure specificity for mdoB-catalyzed reactions.
Mutations in the mdoB gene have profound implications for bacterial membrane composition and function, affecting multiple aspects of bacterial physiology:
Studies demonstrate that mdoB mutants produce membrane-derived oligosaccharides entirely devoid of phosphoglycerol substituents . This chemical alteration results in:
Modified surface charge distribution across the periplasmic face of the inner membrane
Altered interactions with divalent cations that normally bridge between negatively charged groups
Compromised structural integrity of the membrane-periplasm interface
These structural changes translate to several functional impacts:
Osmotic Stress Response
mdoB mutants show increased sensitivity to hypoosmotic shock
Periplasmic solute balance is disrupted under fluctuating environmental conditions
Recovery from osmotic challenge occurs more slowly than in wild-type strains
Membrane Permeability
Subtle increases in membrane permeability to small hydrophilic molecules
Altered antibiotic susceptibility profiles, particularly for compounds targeting cell envelope
Modified outer membrane protein distribution and assembly
Signaling and Adaptation
Activation of envelope stress response pathways
Compensatory changes in other membrane components
Altered expression of genes involved in envelope maintenance
These findings highlight the critical role of phosphoglycerol transferase I in maintaining proper bacterial membrane function through its specific modification of membrane-derived oligosaccharides, with implications for bacterial adaptation to environmental challenges and potential antimicrobial development strategies.
Designing robust inhibition assays for Phosphoglycerol transferase I requires careful consideration of enzyme characteristics, substrate properties, and detection methodologies. The following framework outlines a comprehensive approach:
Enzyme Preparation
Substrate Selection and Optimization
Reaction Conditions Optimization
Using Design of Experiments (DoE) methodology :
Systematically test pH range (6.5-8.0)
Optimize buffer composition (ionic strength, stabilizing agents)
Determine ideal temperature and incubation times
Evaluate effects of potential cofactors and divalent cations
Inhibitor Handling
Prepare stock solutions in appropriate solvents
Verify inhibitor solubility under assay conditions
Include vehicle controls (matching solvent concentrations)
Test for potential interference with detection methods
Data Analysis Framework
Generate IC50 curves with appropriate statistical models
Determine inhibition mechanisms (competitive, non-competitive, etc.)
Calculate Ki values for promising inhibitors
Validate with orthogonal assay methods
This systematic approach enables researchers to develop reliable inhibition assays that can be used for mechanistic studies and potential inhibitor discovery, with applications in fundamental research and possible antimicrobial development.
This methodical framework incorporates Design of Experiments principles to efficiently optimize multiple parameters simultaneously while minimizing experimental variability and resource utilization .